Differentiation of monocyte-derived dendritic cells under the influence of platelets

Cytotherapy

Volumn 10, Issue 7, 2008, Pages 720-729

  Nguyen, X F ^a   Muller Berghaus J ^b,c   Kalsch T ^d   Schadendorf, D ^c   Borggrefe, M ^d   Kluter H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Dendritic cell differentiation; Dendritic cell function; Immunotherapy; Monocytes; Platelet contamination

Indexed keywords

B7 ANTIGEN; CD38 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 4; PROSTAGLANDIN E2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; THROMBOCYTE; THROMBOCYTOPHERESIS;

EID: 56049111894     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802378912     Document Type: Article

References (43)

1. Steinman, RM. (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol, 9, pp. 271-296.
2. Hart, DNJ. (1997) Dendritic cells: Unique leucocyte populations, which control the primary immune response. Blood, 90, pp. 3245-3287.
3. Banchereau, J. and Steinman, RM. (1998) Dendritic cells and the control of immunity. Nature, 392, pp. 245-252.
4. Lotze, MT. (1997) Getting to the source: Dendritic cells as therapeutic reagents for the treatment of patients with cancer. Ann Surg, 226, pp. 1-5.
5. Schadendorf, D. and Nestle, FO. (2000) Autologous dendritic cells for treatment of advanced cancer: An update. Recent Results Cancer Res, 158, pp. 236-248.
6. Jonuleit, H., Kuhn, U. Muller, G. et al. (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulary dendritic cells under fetal calf serum-free conditions. Eur J Immunol, 27, pp. 3135-3142.
7. Thurner, B., Roder, C. Dieckmann, D. et al. (1999) Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods, 223, pp. 1-15.
8. Min, YH, Lee, ST Choi, KM et al. (2000) Surface expression of HLA-DM on dendritic cells derived from CD34-positive bone marrow haematopoietic stem cells. Br J Haematol, 110, pp. 385-393.
9. Mailliard, RB, Wankowicz-Kalinska, A. Cai, Q. et al. (2004) Type-1 polarized dendritic cells: A novel immunization tool with optimized CTL-inducing activity. Cancer Res, 64, pp. 5934-5937.
10. Szabolcs, P., Avigan, D. Gezelter, S. et al. (1996) Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood, 87, pp. 4520-4530.
11. Morse, MA, Zhou, LJ Tedder, TF et al. (1997) Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony stimulating factor, interleukin-4, and tumor necrosis factor-α for use in cancer immunotherapy. Ann Surg, 226, pp. 6-16.
12. Cella, M., Sallusto, F. and Lanzavecchia, A. (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol, 9, pp. 10-16.
13. Nguyen, XD, Eichler, H. Sucker, A. et al. (2002) Collection of autologous monocytes for dendritic cell vaccination therapy in metastatic melanoma patients. Transfusion, 42, pp. 428-432.
14. Gawaz, M., Langer, H. and May, AE. (2005) Platelets in inflammation and atherogenesis. J Clin Invest, 115, pp. 3378-3384.
15. Kalsch, T., Elmas, E. Nguyen, XD et al. (2005) Enhanced coagulation activation by in vitro lipopolysaccharide challenge in patients with ventricular fibrillation complicating acute myocardial infarction. J Cardiovasc Electrophysiol, 16, pp. 858-863.
16. Kalsch, T., Nguyen, XD Elmas, E. et al. (2006) Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina. Int J Cardiol, 111, pp. 217-223.
17. Martinson, JA, Bae, J. Klingemann, H-G et al. (2004) Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC. Cytotherapy, 6, pp. 487-497.
18. Elzey, BD, Sprague, DL and Ratliff, TL. (2005) The emerging role of platelets in adaptive immunity. Cell Immunol, 238, pp. 1-9.
19. Katoh, N., Soga, F. Nara, T. et al. (2006) Effect of serotonin on the differentiation of human monocytes into dendritic cells. Clin Exp Immunol, 146, pp. 354-361.
20. Kissel, K., Berbe, Sr Nockher, A. et al. (2006) Human platelets target dendritic cell differentiation and production of proinflammatory cytokines. Transfusion, 46, pp. 818-827.
21. Nguyen, XD, Eichler, H. Dugrillon, A. et al. (2003) Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. J Immunol Methods, 275, pp. 57-68.
22. Muller-Berghaus, J., Kern, K. Paschen, A. et al. (2004) Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun, 5, pp. 431-434.
23. Scandella, E., Men, Y. Gillessen, S. et al. (2002) Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood, 100, pp. 1354-1361.
24. Elzey, BD, Tian, J. Jensen, RJ et al. (2003) Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity, 19, pp. 9-19.
25. Danese, S., de la Motte, C. Reyes, B. M. et al. (2004) CD40-dependent platelet activation and granular RANTES release: A novel pathway for immune response amplication. J Immunol, 172, pp. 2011-2015.
26. McIlroy, D. and Gregoire, M. (2003) Optimizing dendritic cell-based anticancer immunotherapy: Maturation state does have clinical impact. Cancer Immunol Immunother, 52, pp. 583-591.
27. Schadendorf, D., Ugurel, S. Schuler-Thurner, B. et al. (2006) Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: A randomized phase III trial of the DC study group of the DeCOG. Ann Oncol, 17, pp. 563-570.
28. Figdor, CG, de Vries, IJ Lesterhuis, WJ et al. (2004) Dendritic cell immunotherapy: Mapping the way. Nat Med, 10, pp. 475-480.
29. Morrell, CN, Sun, H. Swaim, AM et al. (2007) Platelets: An inflammatory force in transplantation. Am J Transplant, 7, pp. 2447-2454.
30. Somasundaram, R., Satyamoorthy, K. Caputo, L. et al. (2004) Detection of HLA class II-dependent T helper antigen using antigen phage display. Clin Exp Immunol, 135, pp. 247-252.
31. elGhazali, GE, Paulie, S. Andersson, G. et al. (1993) Number of interleukin-4- and interferon-gamma-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: Distinct response profiles depending on the type of antigen used for activation. Eur J Immunol, 23, pp. 2740-2745.
32. Bocher, WO, Marcus, H. Shakarchy, R. et al. (1999) Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo. Immunology, 96, pp. 634-641.
33. Mayer, S., Laumer, M. Mackensen, A. et al. (2002) Analysis of the immune response against tetanus toxoid: Enumeration of specific T helper cells by the Elispot assay. Immunobiology, 205, pp. 282-289.
34. Trinchieri, G. (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol, 3, pp. 133-146.
35. Ma, X., Chow, JM Gri, G. et al. (1996) The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med, 183, pp. 147-157.
36. Snijders, A., Kalinski, P. Hilkens, CM et al. (1998) High-level IL-12 production by human dendritic cells requires two signals. Int Immunol, 10, pp. 1593-1598.
37. Hilkens, CM, Kalinski, P. de Boer, M. et al. (1997) Human dendritic cells require exogenous interleukin-12- inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood, 90, pp. 1920-1926.
38. Cella, M., Scheidegger, D. Palmer-Lehmann, K. et al. (1996) Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med, 184, pp. 747-752.
39. Osada, T., Nagawa, H. Takahashi, T. et al. (2002) Dendritic cells cultured in anti-CD40 antibody-immobilized plates elicit a highly efficient peptide-specific T-cell response. Immunother, 25, pp. 176-184.
40. Li, L., Masucci, MG and Levitsky, V. (2000) Effect of interleukin-7 on the in vitro development and maturation of monocyte derived human dendritic cells. Scand J Immunol, 51, pp. 361-371.
41. Li, B., VanRoey, MJ and Jooss, K. (2007) Recombinant IL-7 enhances the potency of GM-CSF-secreting tumor cell immunotherapy. Clin Immunol, 123, pp. 155-165.
42. Semino, C., Ceccarelli, J. Lotti, LV et al. (2007) The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion. J Leukoc Biol, 81, pp. 92-99.
43. Dumitriu, IE, Bianchi, ME Bacci, M. et al. (2007) The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol, 81, pp. 84-91.